Prognostic factors of survival in patients with metastatic castration resistant prostate cancer (mCRPC) treated with cabazitaxel: Sequencing might matter
Yazar
Elaidi, Reza-Thierry
Massard, Christophe
Rouge, Thibault De La Motte
Oudard, Stephane
Ozguroglu, Mustafa
Angelergues, Antoine
Maillet, Denis
Flechon, Aude
Mercier, Florence
Guillot, Aline
Le Moulec, Sylvestre
Gravis, Gwenaelle
Beuzeboc, Philippe
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]